Financial - Capital Markets
Compare Stocks
5 / 10Stock Comparison
PJT vs LAZ vs EVR vs MC vs HLI
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
Financial - Capital Markets
PJT vs LAZ vs EVR vs MC vs HLI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets | Financial - Capital Markets |
| Market Cap | $3.70B | $4.36B | $13.11B | $4.69B | $10.71B |
| Revenue (TTM) | $1.71B | $3.19B | $3.88B | $1.52B | $2.39B |
| Net Income (TTM) | $187M | $237M | $592M | $233M | $448M |
| Gross Margin | 32.4% | 31.8% | 99.4% | 99.2% | 38.5% |
| Operating Margin | 21.2% | 13.0% | 20.5% | 18.1% | 21.0% |
| Forward P/E | 20.5x | 14.5x | 17.5x | 20.8x | 19.9x |
| Total Debt | $414M | $2.58B | $1.16B | $267M | $438M |
| Cash & Equiv. | $539M | $1.50B | $1.47B | $509M | $971M |
PJT vs LAZ vs EVR vs MC vs HLI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| PJT Partners Inc. (PJT) | 100 | 280.1 | +180.1% |
| Lazard Ltd (LAZ) | 100 | 172.9 | +72.9% |
| Evercore Inc. (EVR) | 100 | 600.7 | +500.7% |
| Moelis & Company (MC) | 100 | 190.0 | +90.0% |
| Houlihan Lokey, Inc. (HLI) | 100 | 253.7 | +153.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PJT vs LAZ vs EVR vs MC vs HLI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PJT carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (20.5x vs 20.8x)
- Efficiency ratio 0.1% vs MC's 0.8% (lower = leaner)
- Efficiency ratio 0.1% vs MC's 0.8%
Among these 5 stocks, LAZ doesn't own a clear edge in any measured category.
EVR is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 29.5%, EPS growth 54.7%
- 6.1% 10Y total return vs HLI's 6.0%
- 29.5% NII/revenue growth vs LAZ's 3.2%
- +60.9% vs HLI's -5.1%
MC ranks third and is worth considering specifically for defensive.
- Beta 1.75, yield 4.1%, current ratio 21.47x
- 4.1% yield, 1-year raise streak, vs HLI's 1.6%
HLI is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- Lower volatility, beta 0.94, Low D/E 20.1%, current ratio 1.38x
- PEG 1.26 vs PJT's 2.36
- Beta 0.94 vs EVR's 1.90, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 29.5% NII/revenue growth vs LAZ's 3.2% | |
| Value | Lower P/E (20.5x vs 20.8x) | |
| Quality / Margins | Efficiency ratio 0.1% vs MC's 0.8% (lower = leaner) | |
| Stability / Safety | Beta 0.94 vs EVR's 1.90, lower leverage | |
| Dividends | 4.1% yield, 1-year raise streak, vs HLI's 1.6% | |
| Momentum (1Y) | +60.9% vs HLI's -5.1% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs MC's 0.8% |
PJT vs LAZ vs EVR vs MC vs HLI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PJT vs LAZ vs EVR vs MC vs HLI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EVR leads in 2 of 6 categories
MC leads 1 • PJT leads 0 • LAZ leads 0 • HLI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EVR leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
EVR is the larger business by revenue, generating $3.9B annually — 2.6x MC's $1.5B. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to LAZ's 7.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $3.2B | $3.9B | $1.5B | $2.4B |
| EBITDAEarnings before interest/tax | $412M | $384M | $804M | $286M | $591M |
| Net IncomeAfter-tax profit | $187M | $237M | $592M | $233M | $448M |
| Free Cash FlowCash after capex | $614M | $519M | $1.2B | $540M | $739M |
| Gross MarginGross profit ÷ Revenue | +32.4% | +31.8% | +99.4% | +99.2% | +38.5% |
| Operating MarginEBIT ÷ Revenue | +21.2% | +13.0% | +20.5% | +18.1% | +21.0% |
| Net MarginNet income ÷ Revenue | +10.5% | +7.4% | +15.3% | +15.4% | +16.7% |
| FCF MarginFCF ÷ Revenue | +28.0% | +15.9% | +30.5% | +35.6% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +11.1% | -43.8% | +44.2% | -4.3% | +22.3% |
Valuation Metrics
Evenly matched — PJT and LAZ each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, LAZ trades at a 19% valuation discount to HLI's 26.4x P/E. Adjusting for growth (PEG ratio), HLI offers better value at 1.67x vs PJT's 2.63x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.7B | $4.4B | $13.1B | $4.7B | $10.7B |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $5.4B | $12.8B | $4.5B | $10.2B |
| Trailing P/EPrice ÷ TTM EPS | 22.93x | 21.40x | 23.56x | 21.74x | 26.37x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.52x | 14.52x | 17.50x | 20.83x | 19.92x |
| PEG RatioP/E ÷ EPS growth rate | 2.63x | — | 2.08x | — | 1.67x |
| EV / EBITDAEnterprise value multiple | 9.08x | 12.09x | 15.91x | 15.58x | 18.75x |
| Price / SalesMarket cap ÷ Revenue | 2.16x | 1.37x | 3.38x | 3.09x | 4.48x |
| Price / BookPrice ÷ Book value/share | 4.34x | 4.99x | 6.33x | 7.44x | 4.84x |
| Price / FCFMarket cap ÷ FCF | 7.71x | 8.63x | 11.09x | 8.69x | 13.24x |
Profitability & Efficiency
MC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MC delivers a 37.9% return on equity — every $100 of shareholder capital generates $38 in annual profit, vs $20 for PJT. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to LAZ's 2.61x. On the Piotroski fundamental quality scale (0–9), PJT scores 7/9 vs LAZ's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.1% | +26.7% | +29.3% | +37.9% | +20.1% |
| ROA (TTM)Return on assets | +11.1% | +5.2% | +14.1% | +15.9% | +11.9% |
| ROICReturn on invested capital | +20.3% | +9.5% | +18.8% | +24.9% | +15.5% |
| ROCEReturn on capital employed | +21.2% | +9.5% | +17.6% | +22.0% | +20.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 6 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.41x | 2.61x | 0.50x | 0.39x | 0.20x |
| Net DebtTotal debt minus cash | -$125M | $1.1B | -$311M | -$241M | -$533M |
| Cash & Equiv.Liquid assets | $539M | $1.5B | $1.5B | $509M | $971M |
| Total DebtShort + long-term debt | $414M | $2.6B | $1.2B | $267M | $438M |
| Interest CoverageEBIT ÷ Interest expense | — | 4.74x | 32.72x | — | — |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLI five years ago would be worth $24,153 today (with dividends reinvested), compared to $12,061 for LAZ. Over the past 12 months, EVR leads with a +60.9% total return vs HLI's -5.1%. The 3-year compound annual growth rate (CAGR) favors EVR at 46.8% vs LAZ's 21.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -9.5% | -5.6% | -5.5% | -9.4% | -12.6% |
| 1-Year ReturnPast 12 months | +8.3% | +17.8% | +60.9% | +24.4% | -5.1% |
| 3-Year ReturnCumulative with dividends | +152.7% | +80.2% | +216.3% | +104.0% | +85.7% |
| 5-Year ReturnCumulative with dividends | +122.3% | +20.6% | +136.2% | +50.2% | +141.5% |
| 10-Year ReturnCumulative with dividends | +600.7% | +100.4% | +613.3% | +262.4% | +603.4% |
| CAGR (3Y)Annualised 3-year return | +36.2% | +21.7% | +46.8% | +26.8% | +22.9% |
Risk & Volatility
Evenly matched — EVR and HLI each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLI is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than EVR's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EVR currently trades 85.2% from its 52-week high vs HLI's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 1.79x | 1.90x | 1.75x | 0.94x |
| 52-Week HighHighest price in past year | $195.62 | $58.75 | $388.71 | $78.22 | $211.78 |
| 52-Week LowLowest price in past year | $127.73 | $38.67 | $206.63 | $51.06 | $134.41 |
| % of 52W HighCurrent price vs 52-week peak | +78.3% | +79.0% | +85.2% | +81.7% | +72.5% |
| RSI (14)Momentum oscillator 0–100 | 51.2 | 50.9 | 53.0 | 49.1 | 36.6 |
| Avg Volume (50D)Average daily shares traded | 364K | 1.5M | 622K | 1.3M | 606K |
Analyst Outlook
Evenly matched — MC and HLI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PJT as "Hold", LAZ as "Buy", EVR as "Buy", MC as "Hold", HLI as "Buy". Consensus price targets imply 30.3% upside for HLI (target: $200) vs 1.9% for LAZ (target: $47). For income investors, MC offers the higher dividend yield at 4.12% vs PJT's 0.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $158.67 | $47.33 | $382.67 | $73.40 | $200.00 |
| # AnalystsCovering analysts | 12 | 29 | 21 | 22 | 15 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | +3.8% | +1.0% | +4.1% | +1.6% |
| Dividend StreakConsecutive years of raises | 1 | 1 | 0 | 1 | 7 |
| Dividend / ShareAnnual DPS | $0.86 | $1.75 | $3.25 | $2.63 | $2.41 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.3% | +2.1% | +5.0% | +1.6% | +0.5% |
EVR leads in 2 of 6 categories (Income & Cash Flow, Total Returns). MC leads in 1 (Profitability & Efficiency). 3 tied.
PJT vs LAZ vs EVR vs MC vs HLI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PJT or LAZ or EVR or MC or HLI a better buy right now?
For growth investors, Evercore Inc.
(EVR) is the stronger pick with 29. 5% revenue growth year-over-year, versus 3. 2% for Lazard Ltd (LAZ). Lazard Ltd (LAZ) offers the better valuation at 21. 4x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate Lazard Ltd (LAZ) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PJT or LAZ or EVR or MC or HLI?
On trailing P/E, Lazard Ltd (LAZ) is the cheapest at 21.
4x versus Houlihan Lokey, Inc. at 26. 4x. On forward P/E, Lazard Ltd is actually cheaper at 14. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Houlihan Lokey, Inc. wins at 1. 26x versus PJT Partners Inc. 's 2. 36x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PJT or LAZ or EVR or MC or HLI?
Over the past 5 years, Houlihan Lokey, Inc.
(HLI) delivered a total return of +141. 5%, compared to +20. 6% for Lazard Ltd (LAZ). Over 10 years, the gap is even starker: EVR returned +613. 3% versus LAZ's +100. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PJT or LAZ or EVR or MC or HLI?
By beta (market sensitivity over 5 years), Houlihan Lokey, Inc.
(HLI) is the lower-risk stock at 0. 94β versus Evercore Inc. 's 1. 90β — meaning EVR is approximately 103% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 3% for Lazard Ltd — giving it more financial flexibility in a downturn.
05Which is growing faster — PJT or LAZ or EVR or MC or HLI?
By revenue growth (latest reported year), Evercore Inc.
(EVR) is pulling ahead at 29. 5% versus 3. 2% for Lazard Ltd (LAZ). On earnings-per-share growth, the picture is similar: Moelis & Company grew EPS 65. 2% year-over-year, compared to -19. 0% for Lazard Ltd. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PJT or LAZ or EVR or MC or HLI?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus 7. 4% for Lazard Ltd — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PJT leads at 21. 2% versus 13. 0% for LAZ. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PJT or LAZ or EVR or MC or HLI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Houlihan Lokey, Inc. (HLI) is the more undervalued stock at a PEG of 1. 26x versus PJT Partners Inc. 's 2. 36x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Lazard Ltd (LAZ) trades at 14. 5x forward P/E versus 20. 8x for Moelis & Company — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLI: 30. 3% to $200. 00.
08Which pays a better dividend — PJT or LAZ or EVR or MC or HLI?
All stocks in this comparison pay dividends.
Moelis & Company (MC) offers the highest yield at 4. 1%, versus 0. 6% for PJT Partners Inc. (PJT).
09Is PJT or LAZ or EVR or MC or HLI better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 6% yield, +603. 4% 10Y return). Lazard Ltd (LAZ) carries a higher beta of 1. 79 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HLI: +603. 4%, LAZ: +100. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PJT and LAZ and EVR and MC and HLI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PJT is a small-cap quality compounder stock; LAZ is a small-cap income-oriented stock; EVR is a mid-cap high-growth stock; MC is a small-cap high-growth stock; HLI is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.